625 related articles for article (PubMed ID: 18396408)
1. Cathepsin D--many functions of one aspartic protease.
Benes P; Vetvicka V; Fusek M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):12-28. PubMed ID: 18396408
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of cathepsin D.
Vashishta A; Ohri SS; Vetvicka V
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):385-91. PubMed ID: 19807669
[TBL] [Abstract][Full Text] [Related]
3. Procathepsin D as a tumor marker, anti-cancer drug or screening agent.
Vetvicka V; Fusek M
Anticancer Agents Med Chem; 2012 Feb; 12(2):172-5. PubMed ID: 22292775
[TBL] [Abstract][Full Text] [Related]
4. The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor?
Nicotra G; Castino R; Follo C; Peracchio C; Valente G; Isidoro C
Cancer Biomark; 2010; 7(1):47-64. PubMed ID: 21045264
[TBL] [Abstract][Full Text] [Related]
5. Possible role of procathepsin D in human cancer.
Vashishta A; Fusek M; Vetvicka V
Folia Microbiol (Praha); 2005; 50(1):71-6. PubMed ID: 15954536
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D activity and selectivity in the acidic conditions of a tumor microenvironment: Utilization in the development of a novel Cathepsin D substrate for simultaneous cancer diagnosis and therapy.
Achour O; Bridiau N; Kacem M; Delatouche R; Bordenave-Juchereau S; Sannier F; Thiéry V; Piot JM; Maugard T; Arnaudin I
Biochimie; 2013 Nov; 95(11):2010-7. PubMed ID: 23871913
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
[TBL] [Abstract][Full Text] [Related]
8. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity.
Beaujouin M; Liaudet-Coopman E
Adv Exp Med Biol; 2008; 617():453-61. PubMed ID: 18497069
[TBL] [Abstract][Full Text] [Related]
10. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.
Jancekova B; Ondrouskova E; Knopfova L; Smarda J; Benes P
Tumour Biol; 2016 Aug; 37(8):10685-96. PubMed ID: 26867770
[TBL] [Abstract][Full Text] [Related]
11. Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.
Butler VJ; Cortopassi WA; Argouarch AR; Ivry SL; Craik CS; Jacobson MP; Kao AW
J Mol Biol; 2019 Mar; 431(5):1038-1047. PubMed ID: 30690031
[TBL] [Abstract][Full Text] [Related]
12. Detection of procathepsin D in rat milk.
Benes P; Koelsch G; Dvorak B; Fusek M; Vetvicka V
Comp Biochem Physiol B Biochem Mol Biol; 2002 Sep; 133(1):113-8. PubMed ID: 12223218
[TBL] [Abstract][Full Text] [Related]
13. Procathepsin D and cytokines influence the proliferation of lung cancer cells.
Vetvicka V; Vetvickova J
Anticancer Res; 2011 Jan; 31(1):47-51. PubMed ID: 21273579
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents.
Dubey V; Luqman S
Curr Cancer Drug Targets; 2017; 17(5):404-422. PubMed ID: 28215160
[TBL] [Abstract][Full Text] [Related]
15. Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells.
Isidoro C; Baccino FM; Hasilik A
Cell Tissue Res; 1998 May; 292(2):303-10. PubMed ID: 9560473
[TBL] [Abstract][Full Text] [Related]
16. Depletion of procathepsin D gene expression by RNA interference: a potential therapeutic target for breast cancer.
Ohri SS; Vashishta A; Proctor M; Fusek M; Vetvicka V
Cancer Biol Ther; 2007 Jul; 6(7):1081-7. PubMed ID: 17611405
[TBL] [Abstract][Full Text] [Related]
17. Similarities and differences in the biogenesis, processing and lysosomal targeting between zebrafish and human pro-Cathepsin D: functional implications.
Follo C; Ozzano M; Montalenti C; Ekkapongpisit M; Isidoro C
Int J Biochem Cell Biol; 2013 Feb; 45(2):273-82. PubMed ID: 23107604
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic activation of human procathepsin D.
Richo G; Conner GE
Adv Exp Med Biol; 1991; 306():289-96. PubMed ID: 1812719
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
Masson O; Bach AS; Derocq D; Prébois C; Laurent-Matha V; Pattingre S; Liaudet-Coopman E
Biochimie; 2010 Nov; 92(11):1635-43. PubMed ID: 20493920
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells.
Vetvicka V; Vetvickova J; Hilgert I; Voburka Z; Fusek M
Int J Cancer; 1997 Nov; 73(3):403-9. PubMed ID: 9359488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
